FDA panel votes against new Avastin use
AP/Yahoo News, December 7, 2007
Advisors for the Food and Drug Administration say that Genentech's Avastin cancer drug should not be approved for expanded use in breast-cancer patients.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Don't Let Nurses Sink Your Bottom Line
- Hospitals Profit On Bloodstream Infections
- Fortunately, Angelina Jolie Isn't On Medicare
- Less Blood Testing for Some Surgeries Safe, Cost Effective
- Lower ED Margins Demand a Better Strategy
- How Chargemaster Data May Affect Hospital Revenue
- Primary Care Docs Average More Hospital Revenue Than Specialists
- House Lawmakers Grill CMS Over Health Exchange Navigators
- ED Physicians Key to Half of Hospital Admissions
